Health-Related Quality of Life (HRQoL) in men with metastatic Castration-Resistant Prostate Cancer (mCRPC) receiving Talazoparib (TALA): TALAPRO-1

Authors :: Niven Mehra
A. Niyazov
M. Maruzzo
V. Renard
Celestia S. Higano
Howard Gurney
K. Fizazi
G.V. Scagliotti
H. Bhattacharyya
Bhakti Arondekar
Tanya B. Dorff
J-P. Machiels
Philippe Barthélémy
F. Saad
Cynthia G. Healy
A. Stenzl
J.S. de Bono
A. Stirling
Source :: European Urology Open Science. 33:S198-S199
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Health related quality of life
Oncology
medicine.medical_specialty
business.industry
Urology
Castration resistant
medicine.disease
chemistry.chemical_compound
Prostate cancer
chemistry
Internal medicine
Talazoparib
Medicine
business

Tools